s
Gedeon Richter: Cariprazine has a real chance of becoming the best-selling atypical antipsychotic drug
10-04-2024, 11:32
BUDAPEST, Hungary, April 10, 2024 /PRNewswire/ — Cariprazine, an original antipsychotic drug developed by Hungarian pharmaceutical company Gedeon Richter Plc. is available in 64 countries and has become a multiple blockbuster in the US, with sales of nearly $3 billion. It is a unique achievement that a Hungarian drug candidate – discovered and developed locally […] L'articolo Gedeon Richter: Cariprazine has a real chance of becoming the best-selling atypical antipsychotic drug proviene da La Ragione.
CONTINUA A LEGGERE
11
0
0
Guarda anche
La Ragione
10:26
Sostenibilità, i vincitori del Green Economy Award 2024
La Ragione
10:09